Early response to JAK inhibitors on central sensitization and pain catastrophizing in patients with active rheumatoid arthritis

OBJECTIVES: To evaluate the effect of 4 weeks of treatment with Janus kinase inhibitors (JAKis) on central sensitization (CS) and pain catastrophizing, and to determine the pain-related variables predictive of disease activity improvement, in patients with active rheumatoid arthritis (RA). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Salaffi, Fausto, Carotti, Marina, Farah, Sonia, Ceccarelli, Luca, Giovagnoni, Andrea, Di Carlo, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135884/
https://www.ncbi.nlm.nih.gov/pubmed/35505266
http://dx.doi.org/10.1007/s10787-022-00995-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135884/
https://www.ncbi.nlm.nih.gov/pubmed/35505266
http://dx.doi.org/10.1007/s10787-022-00995-z

Ejemplares similares